Status:
COMPLETED
Desmopressin in Cardiac Surgery
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Hemorrhage
Blood Loss, Surgical
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products. Desmopressin (DDAVP), already used for patients with von Willebrand syndro...
Eligibility Criteria
Inclusion
- undergoing cardiac surgery
- excessive bleeding
Exclusion
- age\<18 y
- not signing written consent
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
End Date :
September 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00337766
Start Date
June 1 2006
End Date
September 1 2010
Last Update
October 21 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ospedaliero Fondazione Poliambulanza
Brescia, Italy
2
Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia
Milan, Italy, 20132
3
Istituto Policlinico S.Donato
Milan, Italy
4
Azienda Ospedaliera Universitaria Pisana
Pisa, Italy